Facilitating Efficient Proteomic Analysis With High Throughput Mass Spectrometry Capabilities to Power Drug Discovery Pipelines
8:30 am - Wednesday 4th February 2026
- Evaluating automation, mass spectrometry instruments, and selecting appropriate technologies based on project demands, cost, and internal capabilities
- Achieving optimal levels of throughput and sensitivity to meet project demands
- Reviewing data showing the unique benefit of implementing high-throughput mass spectrometry-based proteomics for degrader profiling in the early stage of drug discovery
